Education, Science, Technology, Innovation and Life
Open Access
Sign In

Valuation Models of Spectrum Pharmaceuticals, Inc.

Download as PDF

DOI: 10.23977/WTED2020.037


Ziyi Wang, Anxuelun Hu, Yuxiang Yao, Jingjian Lu, Yuhan Peng

Corresponding Author

Ziyi Wang


Spectrum Pharmaceuticals, Inc. is a biopharma company, with a primary strategy comprised of acquiring, developing, and commercializing a broad and diverse pipeline of clinical and commercial products. This essay aims at evaluating this company using both the absolute valuation model and the relative valuation model. Advantages and drawbacks of these models will also be discussed.


FCFF valuation model, Price-to-sales valuation model, stock price

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.